Numotech, Inc. Release: Strategic Agreement Forges Rapid-Respond Solution To Bio-Terror Attack

Numotech, Inc. today announced that it has signed a national distribution agreement with Airgas Puritan Medical, the nation’s largest distributor of medical gases, to serve as the exclusive U.S. oxygen supplier to Numotech, Inc. for its flagship product, the Numobag(TM), a disposable, lightweight, wound-healing device used to deliver Topical Hyperbaric Oxygen Therapy (THOT)(TM). The Numobag(TM) is an ideal, rapid-response isolation unit for treating serious chemical, radiological or biologically induced wounds in the event of a terrorist attack. Following the 9/11 World Trade Center attacks, the device was used successfully to treat some of the burn victims. This attracted the attention of the U.S. Government, which soon thereafter awarded the Company a world-wide, five-year federal contract for the sale of the device. The Numobag(TM) is currently used by the military and is being considered by the Department of Homeland Security as a cost-effective addition to its strategic arsenal.